CereVasc is a medical device company that develops a minimally invasive treatment option for communicating hydrocephalus.
CereVasc has raised $85.0M in total funding. The most recent round was Series C. The last funding was announced in June 2026.
CereVasc's investors include Perceptive Advisors, Bain Capital Life Sciences, Medtronic, Johnson & Johnson Innovation, Piper Sandler.
CereVasc is headquartered in Charlestown, United States.
CereVasc is a medical device company that develops a minimally invasive treatment option for communicating hydrocephalus.
CereVasc is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CereVasc — Funding & Investors." VCBacked, June 4, 2026, https://www.vcbacked.co/company/cerevasc. Accessed August 14, 2026.
VCBacked. (2026). CereVasc — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cerevasc
{{cite web |title=CereVasc — Funding & Investors |url=https://www.vcbacked.co/company/cerevasc |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated